![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Goodin D.S.
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 655-670
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapeutic developments in amyotrophic lateral sclerosis
By Lai E.C.
Expert Opinion on Investigational Drugs, Vol. 8, Iss. 4, 1999-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel therapeutic agents for multiple sclerosis
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)